UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO SECTION 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November 2025
Commission File Number: 001-41316
Alpha Tau Medical Ltd.
(Exact Name of Registrant as Specified in Its
Charter)
Kiryat HaMada St. 5
Jerusalem, Israel 9777605
+972 (3) 577-4115
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
CONTENTS
On November 20, 2025, Alpha Tau Medical Ltd. (the “Company”)
issued a press release titled “Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update.” A
copy of this press release is attached to this Form 6-K as Exhibit 99.1.
This Report and the related exhibits are incorporated
by reference into the registrant’s Registration Statements on Form F-3 (File Nos. 333-271073,
333-264306, 333-274457
and 333-288240) and Form S-8
(File Nos. 333-264169, 333-270406,
333-277733 and 333-285745).
EXHIBIT INDEX
| Exhibit No. |
|
Description |
| 99.1 |
|
Press Release dated November 20, 2025 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
Alpha Tau Medical Ltd. |
| |
|
|
| Date: November 20, 2025 |
By: |
/s/ Uzi Sofer |
| |
|
Uzi Sofer |
| |
|
Chief Executive Officer |
